Are third-party telehealth prescriptions of GLP-1s safe?

Medical Economics February 17, 2025
Austin Littrell

Key Takeaways

Two-thirds of PCPs worry about patient safety with third-party telehealth GLP-1 prescriptions, citing overprescribing and continuity of care issues.
Many PCPs are hesitant about compounded GLP-1s, with concerns over regulation, consistency, and safety compared to FDA-approved alternatives.
PCPs emphasize the necessity of lifestyle changes, including diet and exercise, alongside GLP-1 prescriptions for effective weight loss.
GLP-1 prescription requests are more likely approved for patients with cardiometabolic comorbidities or diabetes, highlighting the need for primary care oversight.

In a new Omada Health survey, PCPs warn of safety risks, overprescribing and care gaps regarding GLP-1s for weight loss.

As demand for Glucagon-like peptide-1 (GLP-1) medications for weight loss surges, a new survey of more than 2,000 U.S. primary...

Today's Sponsors